Stan­ford team preps first hu­man CRISPR study for sick­le cell dis­ease cure; Shkre­li fin­gers his for­mer at­tor­neys

Stan­ford sci­en­tists say they have been able to use CRISPR gene edit­ing tech to cor­rect a faulty gene that trig­gers sick­le cell dis­ease. And …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.